NCT04112433View on ClinicalTrials.gov

Novel Cardiac Signal Processing System

CompletedOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

July 20, 2021

Study Completion Date

January 29, 2022

Conditions
Cardiac Arrhythmia
Interventions
DEVICE

PURE EP 2

Enrolled patients receiving cardiac ablation treatment using the current standard of care with additional monitoring and intracardiac electrogram signal collection via the PURE EP 2 system.

Trial Locations (3)

32224

Mayo Clinic Jacksonville, Jacksonville

78758

St. David's Medical Center, Austin

02114

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
lead

BioSig Technologies, Inc.

INDUSTRY